| NCT ID | NCT07192887 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital Medical Center, Cincinnati |
| Condition | Urine Specimen Collection |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-05-07 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2025-05-07 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To develop and validate a urine drug screen to detect thebaine.
Eligibility Criteria
Inclusion Criteria: * Male or female * Ages 18-65 * Healthy Exclusion Criteria: * Allergy to poppy seeds, or any of the related food stuffs used in the study * Celiac disease or gluten sensitivity * Ongoing or opioid use in the past 6 months * History of renal or hepatic disease or dysfunction * Inability or unwillingness to give repeated urine specimens * Unwillingness to refrain from eating poppy seed-containing products during the two-day course of the study * Non-English speakers (due to study materials being in English) * BMI greater than 30 * Antibiotic use in the previous 2 months * Recent ingestion of poppy seeds from the previous 7 days
Contact & Investigator
Charlotte Walter, MD
PRINCIPAL INVESTIGATOR
Children's Hospital Medical Center, Cincinnati
Frequently Asked Questions
Who can join the NCT07192887 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Urine Specimen Collection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07192887 currently recruiting?
Yes, NCT07192887 is actively recruiting participants. Contact the research team at charlotte.walter@cchmc.org for enrollment information.
Where is the NCT07192887 trial being conducted?
This trial is being conducted at Cincinnati, United States.
Who is sponsoring the NCT07192887 clinical trial?
NCT07192887 is sponsored by Children's Hospital Medical Center, Cincinnati. The principal investigator is Charlotte Walter, MD at Children's Hospital Medical Center, Cincinnati. The trial plans to enroll 20 participants.